Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 14 September 2021
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 14 September 2021. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Cont. of BXPHARMA): Sanofi Bangladesh has over 800 employees and produces approximately 100 branded generic products, predominately for the local market. Sanofi Bangladesh has a strong presence in cardiology, diabetes, oncology, dermatology and CNS. Sanofi also supplies its global brands of vaccines, insulins and chemotherapy drugs to Bangladesh through direct imports, which the Group will continue to distribute following the completion of the Acquisition. (Cont. 4)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b0000400527c9
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.